The difference in the epidemiology between carbapenem-resistant klebsiella pneumoniae and carbapenem-resistant acinetobacter baumannii infection

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: LIN, Yu-Jing (Tungs’ Taichung MetroHarbor Hospital, Pharmacy department, Taichung City, China Taiwan)
  • Co-author(s): Yu-Jing Lin: Department of Pharmacy, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Shu-Chen Lai: Department of Pharmacy, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Po-I Chen: Department of Pharmacy, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China;, Taichung City New Pharmacist Association, Taichung, Taiwan, Province of China
    Se-Chin Ke: Infection control committee, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China
    Chin-Ming Chen: Infection control committee, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, Province of China
  • Abstract:

    Background

    The emergence of carbapenem-resistant organisms, especially carbapenem-resistant Klebsiella pneumoniae (CRKP) and Acinetobacter baumannii (CRAB), is the most important pathogens causing infections in healthcare and the rates of resistance is increasing.

    Purpose

    This study aims to investigate the epidemiology factors between patients with..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login